EZH2 and breast carcinoma: Consistent with its anti‐tumoural function, low NKILA expression is associated with breast cancer metastasis and poor patient prognosis.25 While EZH2 is known to promiscuously bind lncRNAs through its cooperation in the PRC2 complex, the existence of direct interaction between EZH2 and NKILA remains to be elucidated.